To fully elucidate the pathophysiology of Charcot-Marie-Tooth disease type 4B3 (CMT4B3) and targetable mechanisms for therapy development, we have engineered a new human peripheral nervous system (PNS) cell model of CMT4B3.
No takes yet. Share an insight, caveat, or question.
Chua et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: